FIELD: chemical-pharmaceutical industry. SUBSTANCE: active substance involving low-soluble compound and if necessary high-soluble compound is mixed with at least one adjuvant exhibiting capability to swell in water and gel formation with adjuvant and high affinity to water. EFFECT: improved method of release. 2 cl, 14 tbl, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING COMPOSITION FOR CONTROLLABLE RELEASE OF ACTIVE COMPOUNDS | 1990 |
|
RU2073998C1 |
| FORM OF PHARMACEUTICAL DOSING PROVIDING THE PROLONGED RELEASE OF AN ACTIVE COMPONENT | 1993 |
|
RU2122413C1 |
| PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2009 |
|
RU2424808C2 |
| COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2436580C1 |
| PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2470637C2 |
| PHARMACEUTICAL COMPOSITION | 2012 |
|
RU2630617C2 |
| SOLID PHARMACEUTICAL PREPARATIONS CONTAINING PHYSICAL MIXTURE OF CYCLODEXTRIN SULFOALKYL ETHER AND THERAPEUTIC AGENT | 1998 |
|
RU2173172C2 |
| SOLID MEDICINAL FORM INTENDED FOR TREATMENT OF ARTERIAL HYPERTENSIA AND STENOCARDIA, AND WAY OF ITS RECEPTION | 2008 |
|
RU2359672C1 |
| THREE-PHASE PHARMACEUTICAL FORM WITH CONSTANT AND CONTROLLED RELEASE OF AMORPHOUS ACTIVE INGREDIENT FOR SINGLE DAILY ADMINISTRATION | 1996 |
|
RU2161956C2 |
| SOLID DOSED OUT FORMS INCLUDING FIBRAT AND STATIN | 2004 |
|
RU2343905C2 |
